Although PAHSAs remain at an experimental stage, their insulin-sensitizing and anti-senescence effects provide compelling proof-of-concept that targeting hyperinsulinemia and its downstream consequences can modulate cellular senescence. The gene discussed is INS; the disease is hyperinsulinism.